Unexplained weight loss (UWL), defined as a loss of more than 5% of body weight within six to twelve months without a clear cause, is a common yet challenging clinical scenario. It can be a harbinger of serious underlying diseases, making its evaluation crucial in clinical practice.
UWL can be attributed to a myriad of conditions. These include malignancies, gastrointestinal disorders, endocrine diseases, infections, and psychiatric illnesses. In some cases, medications or aging may also cause weight loss. However, in approximately 15-25% of cases, the cause remains elusive even after extensive investigation.
A systematic and comprehensive approach to evaluating UWL is essential. A detailed history and physical examination are the cornerstones of diagnosis, often providing clues to the underlying cause. Laboratory tests, imaging studies, and endoscopic procedures may be required based on clinical suspicion. A watchful waiting approach may be appropriate in some patients, given that the cause of UWL may become apparent over time.
While imaging is not routinely recommended in the evaluation of UWL, it may be beneficial in certain scenarios. For instance, CT scans can be useful in detecting occult malignancies or abdominal pathologies. However, the use of imaging should be guided by the patient's history and physical examination findings.
Management of UWL is primarily directed towards treating the underlying cause, if identified. In cases where no cause is found, symptomatic treatment and regular follow-up are essential. Nutritional support may be required in patients with significant weight loss.
In conclusion, evaluating UWL necessitates a comprehensive and systematic approach, with a focus on history taking, physical examination, and judicious use of investigations. While challenging, a meticulous approach can often yield the underlying cause, enabling targeted treatment and improving patient outcomes.
1.
Toward rapid and comprehensive genetic diagnosis of pediatric cancer through adaptive sequencing
2.
Q&A: Why adolescents and young adults with cancer are falling behind
3.
Fixed-Duration Combo Shows Promise for Relapsed MCL
4.
Hospital receives 300 backpacks designed to help kids get leukemia treatment on the go
5.
A study has developed molecular markers that predict meningioma recurrence.
1.
Ultimate Guide to Oncology Services in the USA
2.
Exploring the Benefits of Teclistamab for Treating Advanced Cancer
3.
Glofitamab: A Breakthrough Therapy for Relapsed/Refractory Mantle Cell Lymphoma
4.
The Importance of Iron Rich Foods in Preventing and Treating Anemia
5.
Unexplained Weight Loss: Revealing Occult Cancers and Paraneoplastic Syndromes
1.
International Cancer Conference
2.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
3.
International Cancer Conference
4.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Updates on the First Line Management of ALK+ NSCLC
2.
Dacomitinib Case Presentation: Baseline Treatment and Current Status
3.
Recent Data Analysis for First-Line Treatment of ALK+ NSCLC: A Continuation
4.
Optimizing Treatment Options in Advanced Urothelial Carcinoma
5.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part II
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation